TGFβ is a key modulator of the Epithelial-Mesenchymal Transition (EMT), a process important in cancer progression and metastasis, which leads to the suppression of epithelial genes and expression of mesenchymal proteins. Ionizing radiation was found to specifically induce expression of the TGF-β1 isoform, which can modulate late post-radiation changes and increase the risk of tumor development and metastasis. Interactions between TGFβ induced EMT and DNA damage responses have not been fully elucidated, particularly at low doses and following different radiation quality exposures. Further characterization of the relationship between radiation quality, EMT and cancer development is warranted. We investigated whether space radiation induced TGFβ dependent EMT, using hTERT immortalized human esophageal epithelial cells (EPC2-hTERT) and non-transformed mink lung epithelial cells (Mv1Lu). We have observed morphologic and molecular alterations in EPC2 and Mv1Lu cells consistent with EMT after pre-treatment with TGFβ1. This effect could be efficiently inhibited in both cell lines by the use of a TGFβRI inhibitor. High-energy silicon or iron nuclei were each able to cause a mild induction of EMT, with the inclusion of TGFβ1 inducing a greatly enhanced EMT phenotype even when cells were irradiated with doses as low as 0.1 Gy. A further enhancement of EMT was achieved at a higher dose of 2 Gy. TGFβRI inhibitor was able to reverse the EMT induced by the combination of TGFβ1 and radiation. These studies indicate that heavy ions, even at a low dose, may trigger the process of TGFβ1-induced EMT, and suggest further studies are needed to determine whether the chronic exposures received in space may potentiate this process in astronauts, leading to an increased risk of cancer.
INTRODUCTION
Epithelial-to-mesenchymal transition (EMT) is a cellular process by which an epithelial cell can change its characteristics in response to both intracellular and extracellular signaling events. EMT was initially shown to be important in embryonic development and tissue homeostasis, but more recently has been implicated in wound healing, fibrosis, tumor invasion and metastasis. EMT can be generated through a wide array of mutations, epigenetic events, and inappropriate signaling. The resulting so-called "stemness" is related to an increased clonal population, contributes to a molecular profiles with the diversity observed in malignancies, therefore it is considered a crucial event in malignant progression. 1, 2) The process of EMT includes alterations in cell morphology, cellular architecture, cell adhesion and motility. During EMT, the epithelial characters including apical-basal polarity and specialized cell-cell junctions are lost with nuclear translocation of β-catenin and loss of E-cadherin. 1, 3) Cells gain expression of mesenchymal markers, such as fibronectin and vimentin, show a front-rear polarity associated with weak cell-to-cell contacts, increased motility and resistance to apoptosis. 4) Tumor cells, which gain a more mesenchymal-like phenotype, have shown a migratory capacity at the expense of proliferate potential, and acquire resistance to DNA damage inducers, including chemical agents as well as ionizing radiation, thus becoming resistant to chemotherapy and radiotherapy. 5) Transforming growth factor (TGFβ) is a multifunctional cytokine that modulates cell proliferation, differentiation, apoptosis, and extracellular matrix production. 6) Previous work has shown that during early tumor outgrowth, elevated TGFβ expression is tumor suppressive, whereas at later stages there is a switch whereby continued TGFβ1 expression results in malignant conversion and progression.
6) The biological effect of TGFβ is dependent on the activation of a latent complex, consisting of TGFβ non-covalently associated with its processed N-terminal pro-segment, called the latency-associated peptide (LAP). Release from LAP is a prerequisite for TGFβ to bind to its cell surface receptors. 7) TGFβ is known to play a critical role in EMT, and considered as a "master-switch" of this process. TGFβ mediates its effects through binding to a heteromeric complex of trans-membrane serine/threonine kinases, and a type II receptor, which results in the activation of the receptors and initiation of the Smad-dependent and independent EMT pathways.
Ionizing radiation can cause many cellular effects, including apoptosis, senescence, and genomic instability, which may lead to carcinoma or cell death. Radiation has been shown to lead to LAP-TGFβ activation. Barcellos-Hoff et al. showed a rapid activation of latent TGF-β by radiationinduced reactive oxygen species in mouse mammary glands. [7] [8] [9] They also demonstrated a fast release of TGFβ from its latent form in Fe-irradiated tissue 3 h after irradiation with 0.8 Gy 600 MeV/u Fe nuclei, and noted detectable levels up to 14 days following exposure. The sensitivity of TGFβ1 activation to low doses of radiation exposure and the rapidity with which activation is detected suggests that latent TGFβ1 activation is one of the most responsive indices of tissue response to ionizing radiation.
Several groups have found ionizing radiation can lead to morphological changes consistent with EMT in several cell lines. 9, 10) Non-transformed mink lung epithelial cells (Mv1lu) are highly sensitive to TGFβ1 and have been widely used as a model to study the effects of exogenous TGFβ, including cell cycle arrest, apoptosis and EMT. [11] [12] [13] [14] The effect of ionizing radiation, especially high LET radiation including high charge and energy (HZE) nuclei, however, has not been studied. Most esophageal cancers are squamous-cell type and carry a poor prognosis, frequently presenting at advanced stages with metastasis. In the current work the process of EMT was studied using immortalized human esophageal epithelial cells (EPC2-hTERT), to EMT process, to provide insights into the mechanism of malignant transformation and cancer in this tissue.
In the present study we investigated the effect of high energy Si and Fe nuclei, with LET similar to that observed at the sites of a tumor during carbon therapy, 15) and predominate components in the galactic cosmic rays, 16) on the EMT process in mink lung epithelial cells, in the presence of human recombinant TGFβ1. Our studies show that HZE nuclei are able to induce TGFβ mediated EMT, and suggest a dose-dependent effect in Mv1Lu cells; with similar results being exhibited in human esophageal epithelial cells implying a potential cancer risk following these radiation exposures.
MATERIALS AND METHODS

Cell culture, chemicals and irradiation
The non-transformed Mv1Lu (NBL-7) cell line was purchased from ATCC. The initial culture was established by A. J. Kniazeff, W. A. Nelson-Rees and N. B. Darby, Jr., in 1964, from trypsinized lungs of several nearly full-term, unsexed fetuses of the Aleutian mink. Mv1Lu cells were maintained at 37°C and 5% CO 2 using MEM media supplemented with 10% FBS. hTERT-immortalized human normal esophageal epithelial cells (EPC2-hTERT, a kind gift from Anil Rustgi were cultured in keratinocyte-SFM medium (Invitrogen) supplemented with 50 μg/mL bovine pituitary extract (BPE, Invitrogen), 1.0 ng/mL EGF (Invitrogen), 100 U/mL penicillin, and 100 μg/mL streptomycin (Invitrogen).
Recombinant human TGFβ1 (PeproTech, Rocky Hill, NJ) was added to cells at a concentration of 2.5 ng/ml, for the indicated period of time. A potent TGFβ receptor 1 (TGF-βRI) inhibitor SD208, was purchased from Tocris Bioscience (Ellisville, Missouri). 1 μM SD208 in DMSO (0.1% v/v) or DMSO (0.1% v/v) alone was added to medium 1 hour prior to the addition of TGFβ1.
Experiments using heavy ions were performed at the NASA Space Radiation Laboratory (NSRL) in Brookhaven National Laboratory (BNL, NY). Si nuclei with an energy of 170 MeV/u, and LET of 99 keV/μm, and Fe nuclei with an energy of 600 MeV/u, and LET of 180 keV/μm were delivered at the indicated doses. A 20 × 20 cm 2 beam ensured complete and equal exposure to all samples. The dose rate was between 0.25 to 1 Gy/min dependent upon dose. T25 flasks containing exponentially growing cells were exposed vertically with the cell surface facing the beams. Cells were irradiated 1 h after TGFβ1 treatment and harvested 2 (Mv1Lu) or 3 days (EPC2) after TGFβ1 and/ or Silicon/Iron irradiation.
Western blotting and immunofluorescence
Cells were lysed in M-PER Mammalian Protein Extraction Reagent (Thermo Scientific, Rockford, IL), supplemented with Halt protease inhibitor cocktail (Thermo Scientific). Western blotting was used to detect the protein expression of EMT markers: fibronectin, vimentin, Ecadherin, as well as P-cadherin. After electrophoresis in 8% SDS-PAGE and electroblotting (Bio-Rad, Hercules, CA), the Nitrocellulose membrane was processed according to the instructions of the manufacturer. Antibodies used to visualize EMT markers were purchased from the manufacturers noted. Mouse anti-Vimentin (#V5255) and rabbit antiFibronectin (#F3648) were purchased from Sigma-Aldrich; mouse anti-β-catenin (#2677S) was from Cell signaling Technology Inc; and mouse anti-GAPDH (#AB2302) used as loading control, was from Millipore. After incubation with the corresponding secondary antibodies, the membranes were probed using the enhanced chemiluminescence -Plus kit as recommended by the manufacturer (GE Healthcare). The signal was detected using a Storm 840 scanner (GE Healthcare).
For immunofluorescence, cells were grown on LabTek eight-well chamber slides, and fixed with 4% paraformaldehyde for 10 min, followed by treatment with ice-cold methanol for 10 min. After permeabilization with 0.5% Triton X-100 in PBS for 3 min, cells were blocked with 5% BSA in PBS containing 0.1% Tween 20 and incubated with the indicated primary antibodies, at room temperature for 1 to 2 h. Detection was accomplished using Alexa Fluor 488 or 594 conjugated secondary antibodies (Invitrogen) and nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI). Immunofluorescence was evaluated with a fluorescence microscope Axioplan2 (Zeiss, Sweden).
RESULTS
TGFβ1 is a potent inducer of EMT in esophageal epithelial cells
We first addressed the TGFβ1/Smad signaling pathways with mink lung epithelial cells (Mv1Lu), which has been shown in other studies to elicit a strong TGFβ1 response. 14) Phosphorylation of Smad2 in response to TGFβ1 was detected by western blotting in whole cell lysates of Mv1Lu as early as 1 hour post exposure, consistent with other studies.
12) The expression of Smad7 was also increased shortly after TGFβ1 treatment. A similar TGFβ1 effect was observed in EPC2-hTERT cells, thus, EMT induction was observed with continuous TGFβ1 treatment in both cell lines.
The role of TGFβ1 in regulating EMT was studied by treating exponentially growing cells with a concentration of 2.5 ng/ml TGFβ1, two days for Mv1Lu cells and three days for hTERT-EPC2 cells. EMT was evaluated by alteration of cell morphology, and changes in EMT markers using immunostaining and immunoblotting. Notably, upon TGFβ1 treatment inhibition of cell proliferation was observed in both cell lines; cells lost cell-to-cell contacts and changed from a compact epithelial morphology to a spindle-shaped cell morphology, with significant asymmetry (Fig. 1) . To confirm that these morphological changes corresponded to EMT, markers for epithelial and mesenchymal cells, such as β-catenin, vimentin and fibronectin were assayed for by indirect immunofluorescence. Treatment with TGFβ1 increased the immunostaining of a marker of mesenchymal cells, fibronectin, a glycoprotein that modulates cell morphology, attachment and differentiation, and associated with cancer cell migration and invasion. 17, 18) Vimentin, an intermediate filament protein, showed a basal expression in unstimulated cells, and was up-regulated following TGFβ1 treatment. β-Catenin links E-cadherin and α-catenin to the cytoskeleton to form a complex that maintains normal epithelial polarity and intercellular adhesion. When E-cadherin is down-regulated during EMT, β-catenin accumulates in the cytoplasm and excess levels can be shuttled into the nucleus. 19) Accumulation of β-catenin was observed upon TGFβ1 treatment. These effects were more pronounced when assayed by western blotting using the same antibodies to detect the expression of EMT markers.
HZE nuclei can enhance TGFβ1 induced EMT in epithelial cells
To study how exposure to HZE nuclei may affect EMT induction in human esophageal epithelial cells and mink lung epithelial cells, cells were exposed to Si nuclei (170 MeV/u, and LET 99 keV/μm). Variant doses were delivered of 0.1, 0.4 and 2 Gy and expression of key EMT markers monitored after irradiation. Three days after a single treatment with TGFβ1, alterations in EMT marker signals were noted in EPC cells, including fibronectin, vimentin and β-Catenin, as predicted. Treatment with heavy ions alone was able to marginally induce an EMT phenotype, in a dose-dependent manner. The highest induction being noted following a 2 Gy dose of Si nuclei with a milder effect observed at lower doses. This effect was significantly enhanced when we combined TGFβ and Si nuclei irradiation. Figure 2A shows immunostaining following 0.4 Gy of Si irradiation, where an increase in EMT-like cells is observed as compared to non-irradiated cells, and a further increase is noted after 2 Gy. When EPC cells were dually treated with TGFβ1 and Si nuclei, the fibronectin signal was significantly increased as compared to either single treatment, at a relatively low dose of 0.4 Gy, and a further induction was observed following a higher 2 Gy exposure. Western blotting results support the enhanced EMT signals noted by immunofluorescence in EPC2-hTERT cells as shown in Fig. 2B , demonstrating a dosedependent EMT induction from 0.1 Gy to 2 Gy, and an inhibition of the EMT phenotype with the addition of TGFβ receptor 1 (TGFβRI) inhibitor (shown in the right panel of Fig. 2B ). Similar results were observed in mink lung epithelial cells (Fig. 2C) .
We also performed studies using 600 MeV/u Fe nuclei, with a LET of 180 keV/μm. The results are shown in Fig. 3 and 4 for EPC cells and Mv1Lu cells, respectively. Similar TGFβ1 mediated EMT inductions were noted after Fe nuclei as with Si nuclei, including the alterations of cell morphology and expression of fibronectin. With Fe nuclei exposure as with Si nuclei the mesenchymal transition could be observed following even a low dose (0.1 Gy) and increased doses induced more of an effect, which could be abrogated by TGFβ receptor 1 inhibitor addition. Immunostaining using antibodies directed against fibronectin after different doses of Fe nuclei. C. Western blots using 15 μg of nuclear extracts (NE) or cytoplasmic extracts (CE) or whole cells extracts (WCE) of Mv1Lu cells 48 h after TGFβ1 and/or radiation treatment. Shown also is the expression levels relative to controls (0 Gy, -TGFβ) of fibronectin from western blots of WCE. Details as described in Materials and Methods.
DISCUSSION
The aim of this study was to understand the likelihood of EMT being induced in astronauts' cells following space radiation exposures, or following cancer therapy using high LET radiation such as Si or Fe nuclei. For these studies both hTERT immortalized human esophageal epithelial cells (EPC2-hTERT), and non-transformed mink lung epithelial cells (Mv1Lu) were used to study the possible interactions between EMT and heavy ion exposures.
In this study, we found that TGFβ1, a cytokine which is activated by a number of stimuli, including proteases, thrombospondin-1, reactive oxygen species (ROS) and integrins, 20) can stimulate mesenchymal transition in immortalized human esophageal epithelial cells cultured in a 2D monolayer. Non-transformed Mink lung epithelial cells have long been used as model for TGFβ1/Smad signaling, and in our study these cells were also found to undergo EMT in the presence of TGFβ1. The EMT phenotype was identified by both morphological alterations including loss of cell-cell contact, formation of spindle shape cells, and the expression of mesenchymal cell markers. Fibronectin, a glycoprotein in the extracellular matrix important for processes such as wound healing and embryonic development, is also known as a mesenchymal marker of EMT, and implicated in the development of multiple types of human cancers. 21) Several studies have shown fibronectin expression is implicated in promoting lung cancer growth and migration and conferring resistance to radiation therapy. 22, 23) Therefore altered fibronectin expression was utilized in our studies to monitor the process of mesenchymal transition.
Several studies have shown that ionizing radiation can activate TGFβ1, via free radical generation produced by radiation, and that persistent TGFβ1 signaling can be found 6 days after radiation exposure, and even up to 12 months after localized beta radiation. 8, 24) The mechanism underlying IR-induced EMT may involve Smad signaling, Ras activation, or the Erk/MAPK signaling cascade activated by elevated TGFβ1 levels. Several other oncogenic pathways, such as peptide growth factors, Src, integrin, Wnt/β-catenin and Notch may also induce EMT, as these pathways are also known to be activated following DNA damage.
Most solid tumors are derived from epithelial tissues, and alterations of epithelial and mesenchymal markers have been correlated to the degree of tumor progression. Cellular changes resulting in a more mesenchymal-like state are thought to play a major role in disease progression and have been associated with poor prognosis due to their potential to become metastasic and develop resistance to drug and radiation-induced DNA damage. In addition, recent studies suggest that the EMT population induced is composed primarily of multi-potent progenitor cells. 25) Radiotherapy has been widely used to treat a number of tumors, and high LET radiation has the advantage of increased efficiency of cell killing and improved local control compared with the traditional low LET radiotherapy, thus it is considered an advanced choice for recurrent, metastatic, or un-resectable carcinomas. Nevertheless, according to our results relatively high therapeutic doses of radiation with a LET similar to that used in 12 C therapy, might trigger tumor cell migration shortly after exposure. This potential side effect should be considered during radiotherapy of epithelial carcinoma. The results obtained following TGFβR1 inhibition, however, hold potential promise in offering a possible solution to avoid such an unwanted effect.
Importantly, our study revealed that there is a connection between heavy ion radiation and EMT in normal cells. EMT is frequently linked to radiation induced fibrosis, one of the most common late effects of radiotherapy. In our study, a more significant finding is the enhanced induction of EMT in the presence of TGFβ1 in human esophageal epithelial cells. This has also been noted in human mammary epithelial cells where radiation can sensitize cells to undergo TGFβ1 mediated EMT. 17, 27) In the current study, a range of doses were used to study the dose dependency, and surprisingly a very low dose (0.1 Gy) was shown to produce an additive EMT effect with both Si and Fe nuclei. In space radiation exposures, heavy ions are one of the primary sources of ionizing radiation which threaten the health of astronauts. Doses received by the body in space are moderately low compared to standard radiotherapy; however these studies reveal low doses of heavy ions may still elicit EMT and contribute to a better understanding of factors important in radiation protection in normal tissue. In total, these studies indicate the importance of preventing radiation induced EMT especially during tumor therapy, and suggest that relatively low doses of heavy ions can induce EMT effects. The molecular basis of radiation-enhanced EMT, however, needs further investigation.
